Discover and read the best of Twitter Threads about #DrugPrices
Most recents (22)
🧵Great review of the #340B program, how it has veered away from its intent, and negative consequences for #DrugPrices. | @wasan_kumar @kevin_schulman
Some takeaways follow 👇
Some takeaways follow 👇
2/ “The 340B program was established in response to concerns among safety-net providers regarding the Medicaid Drug Rebate Program, which was enacted in 1990 and required manufacturers to offer their lowest prices to the Medicaid program.”
3/ “An inadvertent effect of [Medicaid Drug Rebate] policy was that safety-net providers lost access to the discounts they had previously received from drug manufacturers. The 340B program was intended to restore discounts to providers caring for low-income and uninsured people.”
While @PhrMA wants you to think companies raise #drugprices to fund R&D, our investigation revealed that drug companies raise prices to:
💰 Turbocharge sales
💰 Keep their stock price growing
Here’s an internal company document admitting they raise prices to fuel “growth”:
💰 Turbocharge sales
💰 Keep their stock price growing
Here’s an internal company document admitting they raise prices to fuel “growth”:
Worse still, drug companies spend far more to reward shareholders than on innovative R&D.
(Read our staff report on buybacks and dividends here: bit.ly/3pGmkR)
Here is the money they make vs. what they spend on R&D for 7 drugs:
(Read our staff report on buybacks and dividends here: bit.ly/3pGmkR)
Here is the money they make vs. what they spend on R&D for 7 drugs:
Our investigation also found that drug companies hike prices for life-saving medications because the U.S. allows them to get away with it.
Here’s an internal document admitting US policy lets the drug company Teva “successfully” raise prices:
Here’s an internal document admitting US policy lets the drug company Teva “successfully” raise prices:
Daily Bookmarks to GAVNet 07/19/2021 greeneracresvaluenetwork.wordpress.com/2021/07/19/dai…
Claudia Sahm on the effects of $1,400 relief payments on families and the economy
jainfamilyinstitute.org/projects/parts…
#commentary #EconomicStimulus #consequences #ReliefPayments
jainfamilyinstitute.org/projects/parts…
#commentary #EconomicStimulus #consequences #ReliefPayments
Biden Executive Order Could Finally Lower Drug Prices
prospect.org/health/biden-e…
#ExecutiveOrders #DrugPrices #PartisanPolitics #legislation
prospect.org/health/biden-e…
#ExecutiveOrders #DrugPrices #PartisanPolitics #legislation
GOP @SenatorCollins voted in favor of @XavierBecerra as #HHS secretary.
Dem @maziehirono was absent from the vote today due to a family emergency.
#pharma #biotech #COVID19 #drugprices #Medicare #Medicaid #ACA #Obamacare #FDA #NIH #CDC #CMS
Dem @maziehirono was absent from the vote today due to a family emergency.
#pharma #biotech #COVID19 #drugprices #Medicare #Medicaid #ACA #Obamacare #FDA #NIH #CDC #CMS
.@XavierBecerra response to being confirmed today by the U.S. Senate as #HHS secretary.
#pharma #biotech #COVID19 #pandemic #drugprices #Medicare #Medicaid #ACA #Obamacare #FDA #NIH #CDC #CMS
#pharma #biotech #COVID19 #pandemic #drugprices #Medicare #Medicaid #ACA #Obamacare #FDA #NIH #CDC #CMS
Here's #HHS @SecBecerra sworn-in & with a new Twitter account
#pharma #biotech #COVID19 #pandemic #drugprices #Medicare #Medicaid #ACA #Obamacare #FDA #NIH #CDC #CMS
#pharma #biotech #COVID19 #pandemic #drugprices #Medicare #Medicaid #ACA #Obamacare #FDA #NIH #CDC #CMS
This happening today: Confirmation of @XavierBecerra to lead #HHS.
Will @POTUS @JoeBiden soon thereafter identify his nominee to lead #FDA?
#pharma #biotech
Will @POTUS @JoeBiden soon thereafter identify his nominee to lead #FDA?
#pharma #biotech
Also today, #NIH Fauci, @CDCDirector Walensky & #FDA Peter Marks are back on Capitol Hill -- virtually -- today along with @DavidAKesslerMD to testify this time at @HELPCmteDems on #COVID19 starting at 10amET help.senate.gov/hearings/exami… #COVIDvaccinations #vaccines #CDC
The House @AppropsDems Commerce, Justice, Science & Related Agencies Subcommittee also examines #COVID19 outbreaks at federal prisons at 2pmET appropriations.house.gov/events/hearing… #MaskUp
1/ Dec. 18, @AmerMedicalAssn wrote to @HHSGov urging it to withdraw the recently issued Most Favored Nation (MFN) Model interim final rule (IFR): tinyurl.com/yajlvlb7
Issue has broad impact on patients, e.g. those who have #cancer, GI, #rheumatology disorders.
Issue has broad impact on patients, e.g. those who have #cancer, GI, #rheumatology disorders.
2/ This IFR would:
•Impact pricing and availability of many of the most expensive Medicare drugs nationwide
•Have serious detrimental impacts on patient access to needed medications
•Create strain and uncertainty for physician practices
•Impact pricing and availability of many of the most expensive Medicare drugs nationwide
•Have serious detrimental impacts on patient access to needed medications
•Create strain and uncertainty for physician practices
3/ @AmerMedicalAssn has long supported efforts to address escalating prescription #drugprices and reduce financial burdens on patients.
However, the MFN IFR is deeply flawed.
However, the MFN IFR is deeply flawed.
The U.S. surpassed 350,000 reported deaths from #COVID19 last night.
gisanddata.maps.arcgis.com/apps/opsdashbo…
And Trump, Pence & Alex Azar are doing what about it today?
Where is the accountability for these deaths?
#MaskUp
gisanddata.maps.arcgis.com/apps/opsdashbo…
And Trump, Pence & Alex Azar are doing what about it today?
Where is the accountability for these deaths?
#MaskUp
#FDA's #VRBPAC doesn't meet until Dec. 10 on $PFE/ $BNTX & Dec. 17 for $MRNA/#NIH vaccines. Does Meadows think he can really push FDA to move the dates up sooner?
What is Meadows & Trump doing to ensure states have enough funding to actually distribute #COVID19 #vaccines?
What is Meadows & Trump doing to ensure states have enough funding to actually distribute #COVID19 #vaccines?
#CDC has scheduled an emergency meeting of #ACIP for Dec. 1 to vote on which groups of Americans should receive the limited initial doses of the #COVID19 #vaccines once those products are cleared for the U.S. market.
Day one today of @OversightDems #drugprices hearing at 10amET: $BMY & its Celgene unit & $TEVA.
oversight.house.gov/legislation/he…
Also, at 11:30amET, @EnergyCommerce #COVID19 #vaccines hearing: energycommerce.house.gov/committee-acti…
oversight.house.gov/legislation/he…
Also, at 11:30amET, @EnergyCommerce #COVID19 #vaccines hearing: energycommerce.house.gov/committee-acti…
.@RepMaloney notes that anyone in the @OversightDems room not wearing #masks will not be recognized at today's #drugpricing hearing.
#drugprices $BMY $TEVA
#drugprices $BMY $TEVA
.@RepMaloney starts out playing clip of @RepCummings, who died last year before he could convene today's #drugpricing hearing.
He notes #pharma one of most powerful/profitable industries in the world.
#DrugPrices #pharma #biotech
He notes #pharma one of most powerful/profitable industries in the world.
#DrugPrices #pharma #biotech
#SCOTUS up first.
What does Trump mean Democrats didn't have the election with #MerrickGarland?
@BarackObama was in the White House!
#2020Debates #2020Debate #RBG #RuthBaderGinsburg
What does Trump mean Democrats didn't have the election with #MerrickGarland?
@BarackObama was in the White House!
#2020Debates #2020Debate #RBG #RuthBaderGinsburg
.@JoeBiden insists should wait on #SCOTUS confirmation & see the outcome of #2020election.
If #Obamacare / #ACA struck down, what happens? Women's rights fundamentally changed.
Not appropriate before election.
#2020Debates #2020Debate #RBG #RuthBaderGinsburg
If #Obamacare / #ACA struck down, what happens? Women's rights fundamentally changed.
Not appropriate before election.
#2020Debates #2020Debate #RBG #RuthBaderGinsburg
If @ABC is still paying @ChrisChristie to be a contributor/commentator, it needs to stop it now.
Christie at White House right now at yet another taxpayer-paid political event, where Trump is making a number of false statements, providing no evidence whatsoever of his claims.
Christie at White House right now at yet another taxpayer-paid political event, where Trump is making a number of false statements, providing no evidence whatsoever of his claims.
And news reporters shouldn't be participating in these types of taxpayer-paid political events at the White House, where they sit quietly by as Trump makes a number of false statements, providing no evidence whatsoever to back up his claims.
This is not a news conference. It is a taxpayer-paid political event, where Trump is using the public airwaves/news publications to spread false/misleading information.
Why are news reporters participating in these taxpayer-paid political events?
Why are news reporters participating in these taxpayer-paid political events?
More allegations emerged that political appointees in the Trump administration have been attempting to interfere with and impose influence on the scientific work of federal agencies to downplay the severity of #COVID19, which has killed nearly 200,000 Americans.
#CDC #FDA #NIH
#CDC #FDA #NIH
Meanwhile, after waiting seven weeks for Trump to reveal the text of his so-called most favored nations executive order for the Medicare Part B program, he revoked the July 24 order on Sept. 13 and replaced it with an amended version, seeking to include the Part D program.
Executive orders simply instruct federal agencies to take certain actions. But the orders have limited authority, can be difficult to enforce without legislation, take months, if not years, to implement and can easily be challenged in court.
#drugprices #drugpricing #pharma
#drugprices #drugpricing #pharma
.@PhRMA spox to me just now: "We are not aware of any meeting."'
So, what was that Trump was saying today ...
#DrugPrices #DrugPricing #pharma #biotech
So, what was that Trump was saying today ...
#DrugPrices #DrugPricing #pharma #biotech
Recall when all those industry executives exited Trump's advisory committees after #Charlottesville, with CEO one of the last to exit.
Since then, many CEOs, including J&J, have returned to White House, attended Trump events.
Given his recent remarks, are they still eager?
Since then, many CEOs, including J&J, have returned to White House, attended Trump events.
Given his recent remarks, are they still eager?
.@PhRMA @steveubl recently was in #JacksonHole with Ivanka & Jared fundraising for Republicans in midst of #COVID19 #pandemic.
What are the optics risks now for #pharma when any Trump event is a wildcard?
What do CEOs think about Trump's recent remarks about #KyleRittenhouse?
What are the optics risks now for #pharma when any Trump event is a wildcard?
What do CEOs think about Trump's recent remarks about #KyleRittenhouse?
And still sitting today.
reginfo.gov/public/do/eoDe…
And still no text of Trump's "favored nations" #drugpricing executive order.
federalregister.gov/presidential-d…
EOs have limited authority, are difficult to enforce, take months/years to implement & can easily be challenged in court.
reginfo.gov/public/do/eoDe…
And still no text of Trump's "favored nations" #drugpricing executive order.
federalregister.gov/presidential-d…
EOs have limited authority, are difficult to enforce, take months/years to implement & can easily be challenged in court.
And International Pricing Index Model For Medicare Part B Drugs proposed rule still pending.
reginfo.gov/public/do/eoDe…
Still no sight of Trump's favored nations EO text
federalregister.gov/presidential-d…
And @PhRMA said no #drugprices meetings it's aware of this week, despite Trump's claim
reginfo.gov/public/do/eoDe…
Still no sight of Trump's favored nations EO text
federalregister.gov/presidential-d…
And @PhRMA said no #drugprices meetings it's aware of this week, despite Trump's claim
Oh, and that health care plan Trump has promised since 2016 - four years ago - still no sight of it yet, either.
So Americans with #PreExistingConditions will just have to keep relying on #Obamacare / #ACA, the law that granted them those protections.
So Americans with #PreExistingConditions will just have to keep relying on #Obamacare / #ACA, the law that granted them those protections.
Honestly, Moderna is an expert at grifting during the #COVID19 pandemic.
This is what every rational government should be watching out for:
Step 1. Convince the US to invest $1.5 billion in your vaccine development, despite no record of vax marketing.
wsj.com/articles/insid…
This is what every rational government should be watching out for:
Step 1. Convince the US to invest $1.5 billion in your vaccine development, despite no record of vax marketing.
wsj.com/articles/insid…
Step 2. Make sure you bolster and research a vaccine the government likely ALREADY owns.
citizen.org/article/the-ni…
citizen.org/article/the-ni…
How to lower prescription drug spending? @MarkMiller_DC explains:
1. End anticompetitive behaviors and reform patent law @WaysMeansCmte @SenFinance #drugprices
1. End anticompetitive behaviors and reform patent law @WaysMeansCmte @SenFinance #drugprices
@MarkMiller_DC @WaysMeansCmte @SenFinance 2. End supply chain distortions – yes, it’s complex, but @MarkMiller_DC breaks it down
@WaysMeansCmte @SenFinance #drugprices
@WaysMeansCmte @SenFinance #drugprices
@MarkMiller_DC @WaysMeansCmte @SenFinance 3. Directly address unjustified annual price increases and prices where PBMs have little leverage.
Both the Senate Finance Committee Bill and HR 3 include an inflationary rebate that will help, says @MarkMiller_DC
@WaysMeansCmte @SenFinance #drugprices
Both the Senate Finance Committee Bill and HR 3 include an inflationary rebate that will help, says @MarkMiller_DC
@WaysMeansCmte @SenFinance #drugprices
.@FrankPallone on cost of sole source drugs w no competition
Asks PBM reps what they can do to control costs on those. PMBs say there's not much besides kicking it off formulary
Pallone: Would Tump's plan scrapping rebates bring down costs of sole source?
PBMs: No
Asks PBM reps what they can do to control costs on those. PMBs say there's not much besides kicking it off formulary
Pallone: Would Tump's plan scrapping rebates bring down costs of sole source?
PBMs: No
Some tension rn btw Express Scripts&Pfizer reps
Pfizer: It's too difficult to get biosimilars on formularies "bc of rebate strategies" 4 original biologic
ES: Disagrees. Biosimilars must add value/cost less. To drugmakers: consider that when they’re launching their list prices
Pfizer: It's too difficult to get biosimilars on formularies "bc of rebate strategies" 4 original biologic
ES: Disagrees. Biosimilars must add value/cost less. To drugmakers: consider that when they’re launching their list prices
Former FDA Commissioner Scott Gottlieb was critical of formulary placement for biosimilars & how it's hampered uptake
My story from Sept news.bloomberglaw.com/pharma-and-lif…
My story from Sept news.bloomberglaw.com/pharma-and-lif…
The hearing begins now. Tune in bit.ly/2CJhEBw
Chairman Grassley calls for transparency in drug pricing!
Senator Wyden is disappointed in the pharmaceutical companies who have declined the invitation to attend today’s hearing. He is eager to work with the committee to get something done about the increased drug pricing.
We're bummed @AcademyHealth #ARM18 is over, so we wanted to share our #policypics from our booth! We asked you what you were excited to talk about at #ARM18 and here are some of your pics! #maternalhealth #opioids #Medicaid #VUHealthPolicyPhD
Thread in response to @LillyPad, for anyone who cares about-
#diabetes
#InsulinPrices
#pharma
#healthcare
#poverty
#health
#drugprices
ETC:
#diabetes
#InsulinPrices
#pharma
#healthcare
#poverty
#health
#drugprices
ETC:
I've been a case manager/patient advocate at a safety net clinic & hospital for many years, working with pt assistance program recipients.
The launch by @LillyPad & @blinkhealth is good, but still problematic- b/c I've seen how Lilly and others place undue burden on patients.
